Bibliographical noteFunding Information:
We thank all members of the Berger laboratory for their contributions. We are grateful to Robert Roth (AstraZeneca) for helpful discussions. The authors thank Francis Stewart for the pRed/ET plasmid. B.G. is supported by the Biotechnology and Biological Research Council (BBSRC) through a scholarship from the South West Doctoral Training Programme, SWDTP. I.B. is supported by a European Research Council ERC Advanced Grant (DNA-DOCK) and is recipient of a Wellcome Trust Senior Investigator Award.
© 2021, Springer Science+Business Media, LLC, part of Springer Nature.
- Bristol BioDesign Institute
- synthetic biology